Caroline Junqueira, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Trypanosoma cruzi | 8 | 2018 | 206 | 1.820 |
Why?
|
Antigens, Protozoan | 5 | 2023 | 316 | 1.270 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2021 | 1351 | 1.030 |
Why?
|
Plasmodium vivax | 3 | 2019 | 202 | 0.790 |
Why?
|
Malaria Vaccines | 2 | 2022 | 164 | 0.780 |
Why?
|
Malaria | 5 | 2023 | 1226 | 0.760 |
Why?
|
Leishmaniasis, Visceral | 2 | 2021 | 99 | 0.740 |
Why?
|
Receptors, IgG | 2 | 2022 | 559 | 0.670 |
Why?
|
Plasmodium | 1 | 2022 | 247 | 0.670 |
Why?
|
Leishmania infantum | 2 | 2021 | 17 | 0.670 |
Why?
|
Immunity, Cellular | 2 | 2018 | 1557 | 0.660 |
Why?
|
Host-Parasite Interactions | 5 | 2021 | 301 | 0.660 |
Why?
|
Leishmaniasis Vaccines | 1 | 2018 | 2 | 0.620 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 4 | 2021 | 899 | 0.590 |
Why?
|
Reticulocytes | 1 | 2018 | 288 | 0.580 |
Why?
|
Cancer Vaccines | 3 | 2014 | 1046 | 0.530 |
Why?
|
Malaria, Falciparum | 2 | 2023 | 1076 | 0.530 |
Why?
|
Chagas Disease | 3 | 2017 | 167 | 0.530 |
Why?
|
Antigens, Neoplasm | 3 | 2014 | 1997 | 0.520 |
Why?
|
Phagocytosis | 2 | 2021 | 1533 | 0.520 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2022 | 4549 | 0.510 |
Why?
|
Erythrocytes | 2 | 2022 | 2413 | 0.490 |
Why?
|
Monocytes | 2 | 2022 | 2570 | 0.440 |
Why?
|
Lymphocyte Activation | 2 | 2021 | 5490 | 0.410 |
Why?
|
Plasmodium falciparum | 2 | 2023 | 1742 | 0.400 |
Why?
|
T-Lymphocytes | 3 | 2018 | 10171 | 0.330 |
Why?
|
Inflammasomes | 3 | 2023 | 527 | 0.320 |
Why?
|
Membrane Proteins | 4 | 2017 | 7843 | 0.290 |
Why?
|
Antibodies, Protozoan | 3 | 2023 | 251 | 0.260 |
Why?
|
Malaria, Vivax | 2 | 2019 | 167 | 0.250 |
Why?
|
Inflammation | 2 | 2022 | 10718 | 0.250 |
Why?
|
Immunological Synapses | 2 | 2023 | 59 | 0.240 |
Why?
|
Caspase 1 | 2 | 2022 | 226 | 0.230 |
Why?
|
Glycoconjugates | 1 | 2024 | 88 | 0.230 |
Why?
|
Leishmania | 1 | 2024 | 75 | 0.230 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 1 | 2023 | 29 | 0.220 |
Why?
|
Killer Cells, Natural | 2 | 2023 | 2201 | 0.210 |
Why?
|
Granzymes | 2 | 2021 | 276 | 0.200 |
Why?
|
Sporozoites | 1 | 2022 | 82 | 0.200 |
Why?
|
Mice, Inbred BALB C | 5 | 2020 | 6209 | 0.200 |
Why?
|
Calreticulin | 1 | 2023 | 114 | 0.200 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2022 | 133 | 0.200 |
Why?
|
Phosphate-Binding Proteins | 1 | 2022 | 93 | 0.190 |
Why?
|
Peptide Hydrolases | 1 | 2024 | 622 | 0.190 |
Why?
|
Plasmodium yoelii | 1 | 2020 | 42 | 0.180 |
Why?
|
Caspase 8 | 1 | 2020 | 189 | 0.170 |
Why?
|
Malaria, Cerebral | 1 | 2020 | 136 | 0.160 |
Why?
|
Serologic Tests | 1 | 2021 | 383 | 0.160 |
Why?
|
Trophoblasts | 1 | 2020 | 224 | 0.160 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2021 | 507 | 0.150 |
Why?
|
Protozoan Proteins | 2 | 2021 | 839 | 0.150 |
Why?
|
Metabolome | 1 | 2024 | 982 | 0.140 |
Why?
|
Brazil | 1 | 2021 | 1217 | 0.140 |
Why?
|
Melanoma, Experimental | 2 | 2023 | 559 | 0.140 |
Why?
|
Lymphocyte Count | 1 | 2018 | 778 | 0.130 |
Why?
|
Interferon-gamma | 2 | 2020 | 3156 | 0.120 |
Why?
|
Animals | 17 | 2024 | 167768 | 0.120 |
Why?
|
RNA-Binding Proteins | 2 | 2021 | 1894 | 0.120 |
Why?
|
Mice | 13 | 2023 | 81101 | 0.110 |
Why?
|
Granulocytes | 1 | 2015 | 550 | 0.110 |
Why?
|
Immunity | 1 | 2019 | 998 | 0.110 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2013 | 90 | 0.110 |
Why?
|
HLA Antigens | 1 | 2018 | 1368 | 0.100 |
Why?
|
Biosynthetic Pathways | 1 | 2013 | 135 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 1 | 2021 | 3733 | 0.100 |
Why?
|
Interferon Type I | 1 | 2015 | 559 | 0.100 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2210 | 0.100 |
Why?
|
Cells, Cultured | 2 | 2021 | 18940 | 0.090 |
Why?
|
Antigens, CD | 1 | 2021 | 3997 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3801 | 0.090 |
Why?
|
Macrophages | 2 | 2022 | 5737 | 0.090 |
Why?
|
Bacteria | 1 | 2020 | 2197 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2012 | 4353 | 0.080 |
Why?
|
Disease Susceptibility | 2 | 2019 | 1788 | 0.080 |
Why?
|
Immunity, Innate | 3 | 2023 | 3047 | 0.080 |
Why?
|
Carica | 1 | 2008 | 10 | 0.080 |
Why?
|
Latex | 1 | 2008 | 49 | 0.080 |
Why?
|
Cell Movement | 1 | 2020 | 5201 | 0.080 |
Why?
|
Dendritic Cells | 3 | 2020 | 2723 | 0.080 |
Why?
|
Neutrophils | 2 | 2023 | 3765 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9304 | 0.070 |
Why?
|
Humans | 21 | 2023 | 758406 | 0.070 |
Why?
|
Immunization | 1 | 2011 | 1227 | 0.070 |
Why?
|
Toll-Like Receptor 9 | 1 | 2008 | 234 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2020 | 22003 | 0.070 |
Why?
|
Adaptive Immunity | 2 | 2023 | 726 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2015 | 1444 | 0.070 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 1038 | 0.070 |
Why?
|
Toll-Like Receptors | 2 | 2020 | 590 | 0.070 |
Why?
|
Neoplasms, Experimental | 1 | 2011 | 1228 | 0.070 |
Why?
|
Mice, Knockout | 4 | 2020 | 14354 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2015 | 2297 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2015 | 2532 | 0.070 |
Why?
|
Plant Proteins | 1 | 2008 | 369 | 0.060 |
Why?
|
Genes, Protozoan | 2 | 2017 | 166 | 0.060 |
Why?
|
Cysteine Endopeptidases | 1 | 2008 | 548 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9574 | 0.060 |
Why?
|
Cytokines | 2 | 2019 | 7338 | 0.060 |
Why?
|
Cell Line, Tumor | 3 | 2020 | 16886 | 0.060 |
Why?
|
Blotting, Western | 1 | 2011 | 5031 | 0.060 |
Why?
|
Glycosphingolipids | 1 | 2024 | 73 | 0.060 |
Why?
|
Cardiolipins | 1 | 2023 | 81 | 0.060 |
Why?
|
Transfection | 1 | 2011 | 5779 | 0.060 |
Why?
|
Merozoite Surface Protein 1 | 1 | 2023 | 38 | 0.060 |
Why?
|
Immunotherapy | 2 | 2021 | 4641 | 0.060 |
Why?
|
Merozoites | 1 | 2023 | 62 | 0.060 |
Why?
|
Endoplasmic Reticulum | 2 | 2023 | 1130 | 0.050 |
Why?
|
Lysosomes | 1 | 2008 | 919 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2011 | 3380 | 0.050 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7590 | 0.050 |
Why?
|
Female | 9 | 2021 | 390323 | 0.050 |
Why?
|
Plasmodium chabaudi | 1 | 2020 | 19 | 0.050 |
Why?
|
Complement System Proteins | 1 | 2024 | 782 | 0.050 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2021 | 72 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2022 | 250 | 0.040 |
Why?
|
Neoplasm Proteins | 2 | 2023 | 3609 | 0.040 |
Why?
|
Chromatography, Affinity | 1 | 2021 | 534 | 0.040 |
Why?
|
NF-kappa B | 1 | 2008 | 2472 | 0.040 |
Why?
|
Aptamers, Nucleotide | 1 | 2021 | 163 | 0.040 |
Why?
|
Male | 6 | 2021 | 358747 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2022 | 1249 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2020 | 576 | 0.040 |
Why?
|
Neuraminidase | 1 | 2017 | 199 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2021 | 1254 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1893 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2118 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2020 | 996 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2020 | 3593 | 0.030 |
Why?
|
Spleen | 1 | 2020 | 2296 | 0.030 |
Why?
|
HeLa Cells | 1 | 2020 | 3096 | 0.030 |
Why?
|
Virulence | 1 | 2017 | 1298 | 0.030 |
Why?
|
Cell Membrane | 1 | 2023 | 3680 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5691 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2872 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2021 | 949 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1765 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2020 | 1723 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2020 | 2204 | 0.030 |
Why?
|
Genetic Complementation Test | 1 | 2013 | 555 | 0.030 |
Why?
|
Genes, Essential | 1 | 2013 | 184 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4540 | 0.020 |
Why?
|
Cell Line | 2 | 2020 | 15591 | 0.020 |
Why?
|
Placenta | 1 | 2020 | 1702 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22032 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1878 | 0.020 |
Why?
|
Pneumonia | 1 | 2022 | 2129 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2021 | 2553 | 0.020 |
Why?
|
Glycoproteins | 1 | 2017 | 2205 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9404 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2796 | 0.020 |
Why?
|
Benzoylarginine Nitroanilide | 1 | 2008 | 2 | 0.020 |
Why?
|
Chromogenic Compounds | 1 | 2008 | 31 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9518 | 0.020 |
Why?
|
X-Ray Diffraction | 1 | 2008 | 420 | 0.020 |
Why?
|
Retroelements | 1 | 2008 | 163 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 3602 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2008 | 778 | 0.020 |
Why?
|
Molecular Weight | 1 | 2008 | 2185 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14641 | 0.020 |
Why?
|
Gene Deletion | 1 | 2013 | 2666 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6520 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8506 | 0.020 |
Why?
|
Rats | 1 | 2020 | 23679 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9468 | 0.010 |
Why?
|
CpG Islands | 1 | 2008 | 1221 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9985 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2008 | 1974 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11892 | 0.010 |
Why?
|
Computational Biology | 1 | 2013 | 3502 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 42062 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13245 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29742 | 0.010 |
Why?
|
Child | 1 | 2023 | 79818 | 0.010 |
Why?
|
Adult | 2 | 2021 | 219935 | 0.010 |
Why?
|
Brain | 1 | 2020 | 26947 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23342 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 58808 | 0.000 |
Why?
|
Middle Aged | 1 | 2015 | 219568 | 0.000 |
Why?
|